Skip to main content
Clinical Trials/NCT05017220
NCT05017220
Completed
Not Applicable

The Effects of Nature-based Sensory Stimulation on Pain in Women With Fibromyalgia: A Randomised Controlled Trial

Universidad de Granada2 sites in 1 country42 target enrollmentJuly 15, 2021
ConditionsFibromyalgia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fibromyalgia
Sponsor
Universidad de Granada
Enrollment
42
Locations
2
Primary Endpoint
Pain intensity
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This randomized controlled trial aims to evaluate the effect of a single session intervention based on a nature-based stimulation program in patients with fibromyalgia

Detailed Description

All participants will continue to receive their usual pharmacological treatment as previously established by the Andalusian Public Health System. The intervention will comprise interaction tasks with biotic and abiotic agents for 30 minutes.

Registry
clinicaltrials.gov
Start Date
July 15, 2021
End Date
August 31, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

José Manuel Pérez Mármol

Principal Investigator / Associate professor

Universidad de Granada

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of fibromyalgia syndrome (ACR criteria 2016).
  • Chronic widespread musculoskeletal pain symptoms (\>1 location using the Widespread Pain Index).
  • High-intensity pain (VAS ≥ 4), at least 3 days a week for the previous 3 months.
  • If currently taking analgesic or psychotropic medications, they had to be stabilised for four or more weeks before the study enrolment
  • Over 18 and less than 65 years old (labour active).
  • Ability to speak and understand English or Spanish.

Exclusion Criteria

  • Acute or temporal pain
  • Severe cognitive impairment, detected by the Mini-Mental State Examination (score \<24 out of 30 points)
  • Severe mental disorders in acute phase or symptomatic phase
  • Behavioural alterations as this may interfere in their participation
  • Severe intellectual disability
  • Other severe or medically unstable diseases interfering with the project participation
  • Co-occurrence of neuropathic pain
  • Other disorders that may cause pain
  • Pregnant or breast-feeding
  • Drug abuse within the past year.

Outcomes

Primary Outcomes

Pain intensity

Time Frame: Change from baseline pain intensity after 30 minutes

Clinical pain intensity assessed by an 11-points Numeric Rating Scale (NRS-11) ranging from 0 to 10

Cold pain thresholds

Time Frame: Change from baseline cold pain thresholds after 30 minutes

Cold pressor test will be used

Punctate mechanical hyperalgesia

Time Frame: Change from baseline mechanical hyperalgesia after 30 minutes

Semmes-Weinstein monofilament (Aesthesio® Precise Tactile Sensory Evaluator, DanMic Global, LLC, San Jose, CA, USA) calibrated to bend at 300 gm (2940 mN; size 6.65; 0.1143 cm in diameter) of pressure with a response-dependent method will be used

Wind-up phenomenon

Time Frame: Change from baseline temporal summation of pain perception after 30 minutes

Wind-up is a frequency- and intensity-dependent increase in the excitability of dorsal horn neuron that results in a temporal summation of pain perception.

Pressure pain thresholds

Time Frame: Change from baseline pressure pain thresholds after 30 minutes

The minimum pressure force which induces pain when pressure is applied on tissues is regarded as the pressure pain threshold

Study Sites (2)

Loading locations...

Similar Trials